UPDATE 1-Teva ready to divest operations to win regulatory nod for Mylan buy

April 22, 2015 4:55 PM

51 0

April 22 (Reuters) - Generic drugmaker Teva Pharmaceutical Industries Ltd said it could "promptly" divest some operations to obtain regulatory clearance for its proposed $40 billion takeover of smaller rival Mylan NV.

Mylan, which has said a merger with Teva would be bad fit, plans to make a new offer for Perrigo Co Plc in the near term, CNBC reported on Wednesday. (cnb.cx/1EbtArn)

Also read: Hong Kong CKI makes $5.4 billion bid for Australian energy Duet Group

Read more

To category page

Loading...